CD8A and infection: Accordingly, we found that a combination of IL-15+ M1/Mdivi+MT pre-treatment increased the frequency of HIV-specific CD8 T cell responses from individuals on ART (Figures 6D, E), and had no effect on the frequency of CMV-specific responses in the same donors (data not shown), in keeping with findings in viraemic infection.